Symyx Acquisition Drives 46 Percent Q3 Revenue Boost for Accelrys

Accelrys reported third-quarter revenue of $29.1 million compared to $20 million for the comparable period of 2009. The year-ago numbers represent financial figures for Accelrys only.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.